Although the COVID vaccine does not contain gp145, Dr Krawczyk said it was wrong to suggest it could in any way lead to HIV, ...

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect. Moderna missed analysts’ revenue expectations by 8.4% last quarter, reporting ...

There was no credible evidence that Gates has been granted approval, secret or otherwise, to spray RNA (including mRNA, a ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the COVID-19 vaccine Spikevax®, targeting the ...

A new study by WashU Medicine researchers found that, in mice, histamine-releasing immune cells act as gatekeepers that protect the brain from infection.

The COVID pandemic likely began when the virus jumped from animals to humans, and didn’t start in a lab. But false narratives ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the ...

Corporate Counsel, in partnership with ALM Intelligence, on Monday released its 2025 General Counsel Report, an exclusive ...

The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...

HCA Healthcare raises 2025 profit forecast amidst insurance uncertainty while Centene anticipates a 2026 profitability boost ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...